TROW
58
5
EL
62
3
MCD
46
8
BDX
61
2
CTAS
33
3
M
37
-3
DTE
43
3
MKC
42
-3
HOG
45
3
XOM
64
8
RF
73
4
CINF
58
-2
ADBE
44
3
EOG
45
3
LYB
20
-9
NFLX
36
-7
DAL
79
2
AXP
71
2
MDLZ
26
-16
PM
52
-4
TROW
58
5
EL
62
3
MCD
46
8
BDX
61
2
CTAS
33
3
M
37
-3
DTE
43
3
MKC
42
-3
HOG
45
3
XOM
64
8
RF
73
4
CINF
58
-2
ADBE
44
3
EOG
45
3
LYB
20
-9
NFLX
36
-7
DAL
79
2
AXP
71
2
MDLZ
26
-16
PM
52
-4
Financhill
Back

Takeda Pharmaceutical Co., Ltd. 10K Form

Buy
52

TAK
Takeda Pharmaceutical Co., Ltd.

Last Price:
$14.28
Seasonality Move:
5.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TAK News And Ratings

See the #1 stock for the next 7 days that we like better than TAK

TAK Financial Statistics

Sales & Book Value

Annual Sales: $30.1B
Cash Flow: $2B
Price / Cash Flow: 8.28
Annual Sales: $15.28
Price / Book: 0.94

Profitability

EPS (TTM): 0.07880
Net Income (TTM): $260.5M
Gross Margin: $16.1B
Return on Equity: 0.55%
Return on Assets: 0.27%

Takeda Pharmaceutical Co., Ltd. Earnings Forecast

Key Takeda Pharmaceutical Co., Ltd. Financial Ratios

  • The Gross Profit Margin over the past 35 years for TAK is 53.59%.
  • The Selling, General & Administrative Expenses for TAK have been equal to 24.11% of Gross Profit Margin.
  • The Research & Development expenses have been 15.94% of Revenue.
  • The Interest Expense is 172.90% of Operating Income.
  • The Net Earning history of TAK is 2.36% of Total Revenues.
  • Per Share Earnings over the last 35 years have been positive in 23 years.

Takeda Pharmaceutical Co., Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TAK
CUSIP: 874060
Website: takeda.com

Debt

Debt-to-Equity Ratio: 0.65
Current Ratio: 1.37
Quick Ratio: 0.64

Price-to-Earnings

Trailing P/E Ratio: 64.9
Forward P/E Ratio: 0

TAK Technical Analysis vs Fundamental Analysis

Buy
52
Takeda Pharmaceutical Co., Ltd. (TAK) is a Buy

Is Takeda Pharmaceutical Co., Ltd. a Buy or a Sell?